Items where Author is "Goebeler, M."

Article

Weiss, L. and Dorman, K. and Boukovala, M. and Schwinghammer, F. and Jordan, P. and Fey, T. and Hasselmann, K. and Subklewe, M. and Buecklein, V. and Bargou, R. and Goebeler, M. and Sayehli, C. and Spoerl, S. and Lueke, F. and Heudobler, D. and Claus, R. and von Luettichau, I. and Lorenzen, S. and Lange, S. and Westphalen, C. B. and von Bergwelt-Baildon, M. and Heinemann, V. and Giessen-Jung, Clemens (2023) Early clinical trial unit tumor board: a real-world experience in a national cancer network. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 149 (14). pp. 13383-13390. ISSN 0171-5216, 1432-1335

Conference or Workshop Item

Glutsch, V. and Kneitz, H. and Gesierich, A. and Goebeler, M. and Posch, C. and Gebhardt, C. and Haferkamp, Sebastian and Zimmer, L. and Becker, J. C. and Leiter-Stöppke, U. and Weichenthal, M. and Schadendorf, D. and Ugurel, S. and Schilling, B. (2022) FV32 REINA - Retrospective Multicenter ADOReg Evaluation of Ipilimumab plus Nivolumab in Avelumab-refractory Merkel cell carcinoma. In: 32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover.

Glutsch, V. and Kneitz, H. and Gesierich, A. and Goebeler, M. and Posch, C. and Haferkamp, S. and Becker, J. C. and Ugurel, S. and Schilling, B. (2021) Ipilimumab plus Nivolumab in Avelumab-refractory Merkel Cell Carcinoma - a retrospective multicenter Analysis. In: 31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, hybrid.

Other

Zhu, G. and Yi, X. and Haferkamp, S. and Hesbacher, S. and Li, C. and Goebeler, M. and Gao, T. and Houben, R. and Schrama, D. (2016) Combination with gamma secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF mutant melanoma cells. ELSEVIER SCIENCE INC, NEW YORK.